부산대학교 도서관

Esteve-Valverde, Enrique; Alijotas-Reig, Jaume; Ferrer-Oliveras, Raquel; Saez-Comet, Luis; Belizna, Cristina; Ruffatti, Amelia; Tincani, Angela; Decarolis, Sara; Latino, Omar; Cervera, Ricard; EUROAPS Study Grp

ANNALS OF THE RHEUMATIC DISEASES; JUN 2019, 78 p1541-p1541, 1p. Supplement: 2

Erkan, Doruk; Andrade, Danieli; Tektonidou, Maria; Ugarte, Amaia; Banzato, Alessandra; Tincani, Angela; Meroni, Pier-Luigi; Cervera, Ricard; Fortin, Paul R.; Levy, Roger A.; APS Action

ARTHRITIS & RHEUMATOLOGY; OCT 2014, 66 pS1253-pS1254, 2p. Supplement: 10

Belon, Joaquin; Manuel Cervera, Jose; Martinez, Antonia; Lopez, Angela

ANNALS OF ONCOLOGY; 2004, 15 p222-p223, 2p. Supplement: 3

Cervera, Isabel; Angel Herraiz, Miguel; Roman, Angela; Antonio Vidart, Jose; Martinez-Laso, Jorge

TISSUE ANTIGENS; MAY 2010, 75 5, p515-p515, 1p.

Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE

Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE

Annals of the Rheumatic Diseases, Vol. 78, no. 6, p. 736-745 (2019)

Clinical pharmacology and therapeutics, Vol. 106, no.2, p. 374-382 (2019)

reponame:Repositorio Institucional EdocUR; instname:Universidad del Rosario; Ludmila E, Neme D, Arbesú G, Dávoli M, Elhelou L, Gastaldo S, et al. Hemofilia. Soc Hematol [Internet]. 2017;12. Available from:; Bolton-Maggs PHB, Pasi KJ. Haemophilias A and B. Lancet. 2003;361(9371):1801-9.; Srivastava A, Brewer AK, Mauser-Bunschoten EP, Key NS, Kitchen S, Llinas A, et al. Guidelines for the Management of Hemophilia. Haemophilia. England; 2013 Jan;19(1):e1-47.; World Federation of Hemophilia. World Federation of Hemophilia Report on the Annual Global Survey 2013. World Fed Hemoph. 2012;(December):54.; Acuña Merchan L, Sánchez Quintero P, Soler Voney LA, Al F. Situación de la hemofilia en Colombia 2015. Cuenta Alto Costo Fondo Colombia enfermedades alto costo [Internet]. Bogota; 2015;1-95. Available from:; Rubiano LP, Vanoy LAS, Ñungo LFA, Martínez A, Bogoya AN. Situación de la hemofilia en Colombia. 2016; Blanchette VS, Key NS, Ljung LR, Manco-Johnson MJ, van den Berg HM, Srivastava A. Definitions in Hemophilia: Communication from the SSC of the ISTH. J Thromb Haemost. 2014;12(11):1935-9.; Departamento de Planeación Nacional.; García-Chávez J, Majluf-Cruz A. Hemofilia. Gac Med Mex. 2013;149:308-21.; Castillo-González D. Hemofilia: aspectos históricos y genéticos. Rev Cuba Hematol Inmunol y Hemoter [Internet]. 2000, Editorial Ciencias Médicas; [cited 2016 Nov 1];28(1):22-33. Available from:; Carcao M. The Diagnosis and Management of Congenital Hemophilia. Semin Thromb Hemost [Internet]. 2012;38(07):727–34. Available from:; World Federation of Hemophilia (WHF). Report of the Annual Global Survey 2016. World Federation Hemoph [Internet]. 2017;514(October):3-73. Available from:; Soucie JM, Evatt B, Jackson D. Occurrence of hemophilia in the United States. The Hemophilia Surveillance System Project Investigators. Am J Hematol. 1998;59(4):288–94.; Acuña L. Boletín de información técnica especializada de la Cuenta de Alto Costo Volumen 4, número 01 [Internet]. Cuenta de Alto Costo. 2018. Available from:; García-Chávez J, Majluf-Cruz A. Hemofilia. 2013;149.; Guzmán Freja A, Siado TI. Hemofilia tipo B en mujeres. Reporte de dos casos Type b Haemophilia in Women. Reports of Two Cases. 2013; Giannelli F, Green PM, Sommer SS, Poon MC, Ludwig M, Schwaab R, et al. Haemophilia B: Database of Point Mutations and Short Additions and Deletions - Eighth edition. Nucleic Acids Res. 1998;26(1):265-8.; Franchini M, Mannucci PM. Hemophilia A in the Third Millennium. Blood Rev [Internet]. Elsevier Ltd; 2013;27(4):179-84. Available from:; J. BC, Melvin S, D. RO. Airway Obstruction in Hemophilia (factor VIII Deficiency): A 28‐Year Institutional Review. Laryngoscope [Internet]. 2009;104(7):789-94. Available from:; E. MH, S. KC. Small Bowel Hematoma in a Hemophiliac as a Cause of Pseudoappendicitis: Diagnosis by ct Imaging. Am J Hematol [Internet]. 2006;38(2):138-9. Available from:; Small S, Rose PE, McMillan N, Belch JJ, Rolfe EB, Forbes CD, et al. Haemophilia and the Kidney: Assessment after 11-Year Follow-Up. BMJ [Internet]. BMJ Publishing Group Ltd; 1982;285(6355):1609–11. Available from:; Alhaosawi M. Guidelines of Management of Musculoskeletal Complications of Hemophilia. J Appl Hematol [Internet]. 2014 Jul 1;5(3):75-85. Available from:; Avina-Zubieta JA, Galindo-Rodriguez G, Lavalle C. Rheumatic Manifestations of Hematologic Disorders. Curr Opin Rheumatol. United States; 1998 Jan;10(1):86-90; Aledort LM, Haschmeyer RH, Pettersson H. A Longitudinal Study of Orthopaedic Outcomes for Severe Factor VIII Deficient Haemophiliacs. J Intern Med. 1994;236:391-9; Jansen NWD, Roosendaal G, Lafeber FPJG. Understanding Haemophilic Arthropathy: an Exploration of Current Open Issues. Br J Haematol. 2008;143(5):632-40; Rauch A, Paris C. Hemostasia primaria. EMC - Tratado Med [Internet]. 2018;22(1):1-12. Available from:; Cervera Bravo A, Álvarez Román MT. Fisiopatología y trastornos de la coagulación hereditarios más frecuentes. Pediatr Integr. 2016; Favaloro EJ, Meijer P, Jennings I, Sioufi J, Bonar RA, Kitchen DP, et al. Problems and Solutions in Laboratory Testing for Hemophilia. Semin Thromb Hemost. 2014;40(1):135; Hay CR, Ludlam CA, Colvin BT, Hill FG, Preston FE, Wasseem N, et al. Factor VIII Inhibitors in Mild and Moderate-Severity Haemophilia A. UK Haemophilia Centre Directors Organisation. Thromb Haemost. Germany; 1998 Apr;79(4):762-6.; Enayat MS, Guilliatt AM, Lester W, Wilde JT, Williams MD, Hill FGH. Distinguishing Between Type 2B and Pseudo-Von Willebrand Disease and its Clinical Importance. Br J Haematol. 2006;133(6):6646.; Bolton-Maggs PHB, Chalmers EA, Collins PW, Harrison P, Kitchen S, Liesner RJ, et al. A Review of Inherited Platelet Disorders with Guidelines for their Management on Behalf of the UKHCDO. Br J Haematol. 2006;135(5):603-33.; Podmore a, Smith M, Savidge G, Alhaq a. Real-time Quantitative PCR Analysis of Factor XI Mrna Variants in Human Platelets. J Thromb Haemost [Internet]. 2004;2(10):1713–9. Available from:; Eshghi P, Abolghasemi H, Sanei-Moghaddam H, Anwar R, Jazebi M, Amid A, et al. Factor XIII Deficiency in South-East Iran. Haemophilia. 2004;10(5):470-2.; Peyvandi F, Duga S, Akhavan S, Mannucci PM. Rare Coagulation Deficiencies. Haemophilia. England; 2002 May;8(3):308-21; Donfield SM, Lynn HS, Lail AE, Hoots WK, Berntorp E, Gomperts ED. Delays in Maturation Among Adolescents with Hemophilia and a History of Inhibitors. Blood. 2007;110(10):3656-61.; White GC 2nd, Rosendaal F, Aledort LM, Lusher JM, Rothschild C, Ingerslev J. Definitions in Hemophilia. Recommendation of the Scientific Subcommittee on Factor VIII and Factor IX of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost. Germany; 2001 Mar;85(3):560.; Caram C, de Souza RG, de Sousa JC, Araujo Pereira T, do Amaral Cerqueira AM, van der Bom JG, et al. The Long-Term Course of Factor VIII Inhibitors in Patients with Congenital Haemophilia a without Immune Tolerance Induction. Thromb Haemost. Germany; 2011 Jan;105(1):59-65.; Kempton CL, Ii GCW. How We Treat a Hemophilia a Patient with a Factor VIII Inhibitor How I Treat How We Treat a Hemophilia a Patient with a Factor VIII Inhibitor. 2014;113(1):11-7.; Bolton-Maggs PHB. Optimal Haemophilia Care versus the Reality. Br J Haematol. England; 2006 Mar;132(6):671-82.; Soucie JM, Nuss R, Evatt B, Abdelhak A, Cowan L, Hill H, et al. Mortality Among Males with Hemophilia: Relations with Source Of Medical Care. The Hemophilia Surveillance System Project Investigators. Blood. United States; 2000 Jul;96(2):437-42.; Oldenburg J. Optimal Treatment Strategies for Hemophilia: Achievements and Limitations of Current Prophylactic Regimens. Blood. 2015;125(13):2038-44.; Andersson NG, Auerswald G, Barnes C, Carcao M, Dunn AL, Fijnvandraat K, et al. Intracranial Haemorrhage in Children and Adolescents with Severe Haemophilia A or B. The Impact of Prophylactic Treatment. Br J Haematol. 2017;179(2):298-307.; Ljung R. The Risk Associated with Indwelling Catheters in Children with Haemophilia. Br J Haematol. 2007;138(5):580-6.; Richards M, Williams M, Chalmers E, Liesner R, Collins P, Vidler V, et al. A United Kingdom Haemophilia Centre Doctors’ Organization Guideline Approved by the British Committee for Standards in Haematology: Guideline on the Use of Prophylactic Factor VIII Concentrate In Children and Adults with Severe Haemophilia A. Br J Haematol. England; 2010 May;149(4):498-507.; Peyvandi F, Garagiola I, Young G. The Past and Future of Haemophilia: Diagnosis, Treatments, and its Complications. Lancet [Internet]. Elsevier Ltd; 2016;388(10040):187-97. Available from:; Mei B, Pan C, Jiang H, Tjandra H, Strauss J, Chen Y, et al. Rational Design of a Fully Active, LongActing Pegylated Factor VIII for Hemophilia a Treatment. Blood. 2010;116(2):270-9.; Chowdary P, Lethagen S, Friedrich U, Brand B, Hay C, Abdul Karim F, et al. Safety and Pharmacokinetics of Anti-TFPI Antibody (Concizumab) in Healthy Volunteers and Patients with Hemophilia: a Randomized First Human Dose Trial. J Thromb Haemost. 2015;13(5):743-54; World Medical Asociation (AMM). Declaración de Helsinki de la AMM - Principios éticos para las investigaciones médicas en seres humanos. World Med Assoc Inc [Internet]. 2013;1-8. Available from:; Ministerio de Salud. Resolución 8430 de 1993. Ministerio de Salud y Protección Social República de Colombia. 1993;1993(Octubre 4):1-19; Rodríguez-Merchan EC. Musculoskeletal Complications of Hemophilia. HSS J. 2010;6(1):37-42.; Chang CY, Li TY, Cheng SN, Pan RY, Wang HJ, Lin SY, et al. Prevalence and Severity by Age and other Clinical Correlates of Haemophilic Arthropathy of the Elbow, Knee and Ankle Among Taiwanese Patients with Haemophilia. Haemophilia. 2017;23(2):284-91.; Knobe K, Berntorp E. Haemophilia and Joint Disease: Pathophysiology, Evaluation, and Management. J Comorbidity. 2011;11:51-5951.; Carpenter SL, Michael Soucie J, Sterner S, Presley R. Increased Prevalence of Inhibitors in Hispanic Patients with Severe Haemophilia a Enrolled in the Universal Data Collection Database. Haemophilia. 2012;18(3):1-6.; Oliveira M, Duarte E. Guidelines for the Management of Hemophilia. Haemophilia. 2012;(20).